ACE2 POLYPEPTID

European patent · EP2155871 · In force

Register entry

Publication number
EP2155871
Application number
EP08756821
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 12, 2008
Published
Feb 24, 2010
Granted
Aug 12, 2015
Protection ends at the latest
Jun 11, 2028
Next annual fee due
Jun 30, 2027
IPC classes
C12N 9/64 (2006.01)
A61K 38/48 (2006.01)
Priority
AT 9132007 12.06.2007
EP 08450052 08.04.2008
PCT application
PCT/AT2008/000211 12.06.2008
PCT publication
WO2008/151347 18.12.2008
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Oct 9, 2015

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 09.10.2015

  7. Aug 12, 2015

    Granted

    Published in Swissreg on 12.08.2015

Parties

Holder

Apeiron Biologics AG

Campus-Vienna-Biocenter 5, 1030 Wien, AT

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

SCHUSTER, Manfred

A-2191 Schrick, AT

LOIBNER, Hans

A-1230 Wien, AT

JANZEK-HAWLAT, Evelyne

A-1230 Wien, AT

PEBALL, Bernhard

A-1070 Wien, AT

STRANNER, Stefan

A-1230 Wien, AT

WAGNER, Bettina

A-2700 Wiener Neustadt, AT

WEIK, Robert

A-2724 Hohe Wand-Stollhof, AT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.